Life-threatening allergic bronchopulmonary aspergillosis in a well child with cystic fibrosis

Med J Aust. 2005 May 2;182(9):482-3. doi: 10.5694/j.1326-5377.2005.tb06792.x.

Abstract

Allergic bronchopulmonary aspergillosis (ABPA) is an uncommon condition which may complicate asthma and cystic fibrosis; it is seldom considered life-threatening. We report a well 8-year-old boy with cystic fibrosis and normal lung function who progressed to respiratory failure over several days, attributable to ABPA. He recovered with non-invasive ventilation and oral corticosteroid and antifungal medications, regaining normal lung function within 2 months. To our knowledge, such an acute severe presentation of ABPA in a previously well child has not been reported before.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Fungal / blood
  • Aspergillosis, Allergic Bronchopulmonary / complications*
  • Aspergillosis, Allergic Bronchopulmonary / diagnosis*
  • Aspergillosis, Allergic Bronchopulmonary / drug therapy
  • Aspergillus fumigatus* / immunology
  • Child
  • Cystic Fibrosis / complications*
  • Forced Expiratory Volume
  • Humans
  • Immunoglobulin E / blood
  • Male
  • Respiratory Insufficiency / microbiology*

Substances

  • Antibodies, Fungal
  • Immunoglobulin E